How Does Malaria Affect Pregnancy? Which Treatments Are Safe
At a Glance
Malaria in pregnancy can cause severe illness, anemia, premature delivery, low birth weight, miscarriage, or stillbirth, but prompt clinician-guided treatment is effective. The safest medicine depends on the malaria species, severity, drug resistance, and trimester; severe cases require IV artesunate.
In this answer
3 sections
Malaria during pregnancy requires urgent medical assessment and prompt treatment. The infection poses severe risks to both the pregnant person and the developing baby, including maternal anemia, low birth weight, and premature delivery [1][2]. Fortunately, safe and highly effective antimalarial treatments are available. The specific medication prescribed will depend on the malaria species, the severity of the infection, local drug resistance, and your current trimester [3][4]. However, liver-clearing medications used for certain relapsing species are contraindicated (must not be used) during pregnancy [5].
What to do now:
Seek same-day urgent medical care if you are pregnant and have a fever or suspect you have malaria. Do not wait for a routine appointment, and do not start or stop an antimalarial drug without a clinician’s guidance.
Seek immediate emergency hospital care if you experience any of these severe warning signs:
- Confusion, seizures, fainting, or extreme weakness
- Difficulty breathing
- Jaundice (yellowing of the eyes or skin)
- Repeated vomiting or inability to keep fluids and medications down
- Reduced fetal movement (if you are far enough along to normally feel movement)
How Malaria Affects Pregnancy
Pregnancy causes changes in the immune system, making pregnant people more susceptible to malaria infections and more likely to experience severe symptoms.
Risks to the Pregnant Person
Malaria destroys red blood cells, which can lead to severe maternal anemia (a dangerously low red blood cell count) [1]. In cases of severe Plasmodium falciparum (P. falciparum)—the deadliest species of the malaria parasite—the infection can become life-threatening, potentially causing complications like coma, respiratory failure, or maternal mortality [6].
Risks to the Baby
The infection can disrupt the flow of nutrients through the placenta, leading to serious fetal complications. Both P. falciparum and P. vivax (another common malaria species) increase the risk of:
- Low birth weight and small-for-gestational-age development (a baby that is smaller than usual for the number of weeks of pregnancy) [2][7]
- Premature delivery (birth before 37 weeks) [2]
- Miscarriage and stillbirth [2][8]
While these risks are serious, they are increased risks, not absolute predictions. Many pregnant people recover fully and deliver healthy babies with prompt, appropriate treatment.
Safe Treatments During Pregnancy
The risks of untreated malaria far outweigh the risks of approved antimalarial drugs. Your local malaria and obstetric care team must choose your specific regimen based on the species, your health, and geographic drug resistance.
Uncomplicated Malaria
For uncomplicated cases (where there are no severe emergency symptoms), oral medications are used to clear the active parasites from the blood:
- First Trimester: The World Health Organization (WHO) recommends artemether-lumefantrine (AL) as a preferred treatment for uncomplicated P. falciparum malaria in the first trimester. Available observational data have not shown an increased risk of miscarriage, stillbirth, or major birth defects associated with its use [3][9].
- Second and Third Trimesters: Artemisinin-based combination therapies (ACTs), which include AL, are highly effective and are the recommended first-line treatments later in pregnancy [10][11].
- Chloroquine-Susceptible Species: For species like P. vivax that are acquired in regions where they are vulnerable to chloroquine, this medication remains an effective and safe option to clear the acute blood infection [12][4].
Severe Malaria
Severe malaria is a life-threatening emergency in any trimester and requires immediate hospital-level intensive care. The preferred and most effective treatment is intravenous (IV) artesunate [13][14].
Treatment should never be delayed. If IV artesunate is unavailable, the medical team will use an alternative based on local protocols (such as IV quinine), which requires careful monitoring for side effects like severe low blood sugar [4].
Preventing Relapse: Liver-Clearing Drugs and Pregnancy
Some malaria species (specifically P. vivax and P. ovale) can leave dormant parasites hiding in the liver. These can wake up later and cause a relapse. To completely cure these infections, doctors use 8-aminoquinoline drugs (such as primaquine or tafenoquine) to clear the liver [5].
Primaquine and tafenoquine are contraindicated (must not be used) during pregnancy.
These drugs can cause oxidant hemolysis (severe, rapid destruction of red blood cells) in individuals who have a genetic condition called G6PD deficiency [5][15]. Because fetal G6PD status is not routinely available or safe to establish during pregnancy, these medications cannot be given to a pregnant person [5].
What is the alternative during pregnancy?
Instead of liver-clearing drugs, your doctor may prescribe a suppressive strategy, such as a weekly dose of chloroquine prophylaxis, to prevent relapses for the remainder of your pregnancy [16][4]. This depends on the specific malaria species and local chloroquine resistance, and it is a clinician-directed plan, not a universal substitute for acute treatment.
What happens after delivery?
Once you have delivered, you must undergo mandatory quantitative G6PD testing before any liver-clearing drugs can be prescribed [17].
If you plan to breastfeed, the decision requires careful evaluation. WHO guidance restricts primaquine during breastfeeding for infants younger than 6 months, or if the infant’s G6PD status is unknown or deficient [18]. Tafenoquine can also transfer into breast milk [19]. Postpartum primaquine may only be considered during breastfeeding if both you and your infant have been tested, have normal G6PD levels, and your doctor determines it aligns with local guidelines [20][17]. Never start these medications without explicit clearance from your care team.
Common questions in this guide
Is malaria dangerous during pregnancy?
What should I do if I am pregnant and think I have malaria?
Which malaria medicines can be used during pregnancy?
What is the emergency treatment for severe malaria during pregnancy?
Can I take primaquine or tafenoquine while pregnant?
How is the risk of malaria relapse managed after pregnancy?
Related questions
Show more
Get notified when new evidence is published on Malaria.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (20)
- 1
Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study.
Bardají A, Martínez-Espinosa FE, Arévalo-Herrera M, et al.
PLoS neglected tropical diseases 2017; (11(6)):e0005606 doi:10.1371/journal.pntd.0005606.
PMID: 28604825 - 2
Adverse pregnancy outcomes in maternal malarial infection: A systematic review and meta-analysis.
Satapathy P, Khatib MN, Gaidhane S, et al.
New microbes and new infections 2024; (62()):101474 doi:10.1016/j.nmni.2024.101474.
PMID: 39286328 - 3
Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
Saito M, McGready R, Tinto H, et al.
Lancet (London, England) 2023; (401(10371)):118-130 doi:10.1016/S0140-6736(22)01881-5.
PMID: 36442488 - 4
UK malaria treatment guidelines 2016.
Lalloo DG, Shingadia D, Bell DJ, et al.
The Journal of infection 2016; (72(6)):635-649 doi:10.1016/j.jinf.2016.02.001.
PMID: 26880088 - 5
Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J, Taylor WRJ, Bancone G, et al.
PLoS neglected tropical diseases 2018; (12(4)):e0006440 doi:10.1371/journal.pntd.0006440.
PMID: 29677199 - 6
Severe falciparum malaria in pregnancy in Southeast Asia: a multi-centre retrospective cohort study.
Saito M, Phyo AP, Chu C, et al.
BMC medicine 2023; (21(1)):320 doi:10.1186/s12916-023-02991-8.
PMID: 37620809 - 7
Malaria during pregnancy and newborn outcome in an unstable transmission area in Brazil: A population-based record linkage study.
Dombrowski JG, de Souza RM, Silva NRM, et al.
PloS one 2018; (13(6)):e0199415 doi:10.1371/journal.pone.0199415.
PMID: 29928025 - 8
Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis.
Moore KA, Fowkes FJI, Wiladphaingern J, et al.
BMC medicine 2017; (15(1)):98 doi:10.1186/s12916-017-0863-z.
PMID: 28486979 - 9
Defining safety parameters for first-trimester malaria treatment trials: stakeholder views from Real-Time Delphi survey.
Bivegete S, Barsosio H, El Gaaloul M, et al.
Malaria journal 2026; (25(1)).
PMID: 42471622 - 10
Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study.
Nambozi M, Tinto H, Mwapasa V, et al.
Malaria journal 2019; (18(1)):105 doi:10.1186/s12936-019-2737-7.
PMID: 30922317 - 11
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Saito M, Mansoor R, Kennon K, et al.
The Lancet. Infectious diseases 2020; (20(8)):943-952 doi:10.1016/S1473-3099(20)30064-5.
PMID: 32530424 - 12
Diagnosis, Treatment, and Prevention of Malaria in the US: A Review.
Daily JP, Minuti A, Khan N
JAMA 2022; (328(5)):460-471 doi:10.1001/jama.2022.12366.
PMID: 35916842 - 13
Treating severe malaria in pregnancy: a review of the evidence.
Kovacs SD, Rijken MJ, Stergachis A
Drug safety 2015; (38(2)):165-81 doi:10.1007/s40264-014-0261-9.
PMID: 25556421 - 14
Malaria in the Intensive Care Unit.
Hegde A
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2021; (25(Suppl 2)):S127-S129 doi:10.5005/jp-journals-10071-23871.
PMID: 34345125 - 15
Approval of Tafenoquine for Malaria Chemoprophylaxis.
Berman JD
The American journal of tropical medicine and hygiene 2019; (100(6)):1301-1304 doi:10.4269/ajtmh.19-0001.
PMID: 30887947 - 16
ASSESSMENT OF THE EFFICACY AND SAFETY OF CHLOROQUINE MONOTHERAPY FOR THE TREATMENT OF ACUTE UNCOMPLICATED GESTATIONAL MALARIA CAUSED BY P. VIVAX, CÓRDOBA, COLOMBIA, 2015-2017.
Castro-Cavadía CJ, Carmona-Fonseca J
Revista colombiana de obstetricia y ginecologia 2020; (71(1)):21-33 doi:10.18597/rcog.3370.
PMID: 32418373 - 17
Tafenoquine and G6PD: a primer for clinicians.
Chu CS, Freedman DO
Journal of travel medicine 2019; (26(4)) doi:10.1093/jtm/taz023.
PMID: 30941413 - 18
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
Abla N, Marrast AC, Jambert E, et al.
Malaria journal 2024; (23(1)):287 doi:10.1186/s12936-024-05112-9.
PMID: 39334094 - 19
Tafenoquine lactation pharmacokinetics: a pilot study.
Gilder ME, Wattanakul T, Tarning J, et al.
Malaria journal 2025; (25(1)):15 doi:10.1186/s12936-025-05685-z.
PMID: 41345660 - 20
Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures.
Gilder ME, Hanpithakphong W, Hoglund RM, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018; (67(7)):1000-1007 doi:10.1093/cid/ciy235.
PMID: 29590311
This page explains the risks of malaria in pregnancy and commonly used treatments for informational purposes only and does not constitute medical advice. Because malaria during pregnancy can become an emergency, seek prompt care and follow your obstetric and malaria care team's instructions.